For citations:

Kolyadina I.V. Escalation of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer: to whom, when and why? Tumors of female reproductive system. 2024;20(1):89-103. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-1-89-103